HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,875 | -5.1% | 50,000 | -3.5% | 0.00% | – |
Q2 2023 | $37,816 | +13.4% | 51,803 | -6.8% | 0.00% | – |
Q1 2023 | $33,348 | +50.5% | 55,580 | -1.5% | 0.00% | – |
Q4 2022 | $22,157 | -64.8% | 56,436 | -0.2% | 0.00% | – |
Q3 2022 | $63,000 | +26.0% | 56,541 | +0.2% | 0.00% | – |
Q2 2022 | $50,000 | -54.5% | 56,444 | +0.4% | 0.00% | – |
Q1 2022 | $110,000 | -15.4% | 56,244 | -1.1% | 0.00% | – |
Q4 2021 | $130,000 | -13.9% | 56,844 | +8.7% | 0.00% | – |
Q3 2021 | $151,000 | – | 52,282 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 194,718 | $171,000 | 0.22% |
RPO LLC | 83,705 | $74,000 | 0.02% |
Sio Capital Management, LLC | 49,998 | $45,000 | 0.02% |
CVI Holdings, LLC | 244,825 | $218,000 | 0.02% |
Exos Asset Management LLC | 27,151 | $24,000 | 0.01% |
TUDOR INVESTMENT CORP ET AL | 236,549 | $208,000 | 0.01% |
LMR Partners LLP | 50,000 | $161,000 | 0.00% |
P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $17,000 | 0.00% |
Verition Fund Management LLC | 15,000 | $48,000 | 0.00% |
JANE STREET GROUP, LLC | 56,444 | $50,000 | 0.00% |